Fig. 10

The schematic diagram for the mechanism of the therapeutic effect of PMVs on VEC functions in sepsis. PMVs delivered CTGF to VECs and activating the CTGF-ERK1/2-STAT3 axis, and subsequently improved the proliferation and angiogenesis ability in VECs, thereby restoring vascular functions in sepsis